Skip to main content

Advertisement

Fig. 1 | BMC Medicine

Fig. 1

From: Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda

Fig. 1

Treatment outcomes. PZQ praziquantel, ALB albendazole, IVM ivermectin. A treated individual was someone eligible for MDA and who was offered and ingested at least one drug of PZQ, ALB, or IVM from a CMD during 1 month of MDA. A treated household comprised at least one eligible person in the home who was offered and had ingested at least one drug of PZQ, ALB, or IVM from a CMD during 1 month of MDA. a Breakdown of treatment outcomes for 31 villages by household and individual. b Scatter plot of treatment outcomes for CMDs. Pearson r = 0.968, p < 0.0001

Back to article page